Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457391 · ClinicalTrials.gov registry record · Phase 3
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
A Phase 3 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 443
- Enrollment target
- 4
- Study locations
NCT01457391 is a Phase 3 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 443 participants, above the 149-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (197% higher). The trial reports 4 study locations across 1 state.
The verdict
NCT01457391, a Phase 3 study of Stress Disorders, Post-Traumatic and Substance-Related Disorders, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 443 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this phase of the study is to assess the efficacy of CBT for PTSD, as delivered by routine addiction counselors in community treatment programs, and to compare CBT for PTSD with both Individual Addiction Counseling (IAC) and Treatment as Usual (TAU) on the primary outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Treatment-as-usual
- BEHAVIORAL Individual Addiction Counseling
Study Locations (4)
Vermont
- Central Vermont Substance Abuse Services - Berlin Corners
- Brattleboro Retreat - Brattleboro
- Howard Center - Burlington
- Evergreen - Rutland Mental Health - Rutland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 443 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01457391
The ClinicalTrials.gov registry entry for NCT01457391 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 443 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 149-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (197% higher). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01457391 reports 4 study locations spanning 1 distinct geographic area - top geographies include Vermont.
Frequently Asked Questions
What is clinical trial NCT01457391 about?
NCT01457391 is a clinical study titled "Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment". The purpose of this phase of the study is to assess the efficacy of CBT for PTSD, as delivered by routine addiction counselors in community treatment programs, and to compare CBT for PTSD with both Individual Addiction Counseling (IAC) and Treatment as Usual (TAU) on the primary outcomes.
What is the current status of trial NCT01457391?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 443 participants. The study started on 2010-12. Estimated completion is 2014-04.
What conditions does trial NCT01457391 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic, Substance-Related Disorders.
What interventions are being tested in trial NCT01457391?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Treatment-as-usual (BEHAVIORAL), Individual Addiction Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01457391?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01457391 being conducted?
This trial has 4 study locations across Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).
COMPLETED · Phase 3
-
Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
COMPLETED · Phase 3
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Overcontrol and Suicide in PTSD
RECRUITING
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.